Pricing Log in Create free account

MBX Biosciences, Inc. (MBX) vs Palvella Therapeutics, Inc. (PVLA)

MBX Biosciences, Inc. and Palvella Therapeutics, Inc. are both Biotechnology companies. MBX Biosciences, Inc. and Palvella Therapeutics, Inc. are of similar size ($2.3B and $2.3B). Across the 8 metrics below, MBX Biosciences, Inc. leads on 4 and Palvella Therapeutics, Inc. on 4.

Valuation

Metric MBX PVLA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 60.13 9.40
P/B 5.97 11.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 54.13 9.02
Earnings yield (4.70%) (2.77%) (32.88%)
Free cash flow yield (3.48%) (1.28%) (23.13%)

Profitability

Metric MBX PVLA Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.17%) (46.63%) (51.96%)
Return on assets (31.25%) (37.70%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MBX PVLA Biotechnology median
Revenue growth (TTM) — 146.67% 6.76%
EPS growth (last fiscal year) 59.11% 52.62% 29.88%
Revenue growth, 5-year CAGR — 8.03% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MBX PVLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 18.08 21.18 4.97
Net debt to EBITDA 3.82 1.50 1.01

Dividend

Metric MBX PVLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MBX PVLA Biotechnology median
Market cap 2.33b 2.26b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack